Why does a "24% flavone glycosides / 6% lactones" COA still not prove the ginkgo extract is authentic?

Answer-first: Because the 24% assay is calculated after hydrolysis and can be inflated with cheap flavonols from other plants. Adding rutin (from Japanese pagoda tree / buckwheat), quercetin or kaempferol raises the "total flavonol glycosides" reading while destroying the natural ginkgo fingerprint — and published surveys show this is common: one fingerprint study of UK retail products found only 2 of 35 matched the pharmacopoeial HPTLC pattern, and multiple studies identify rutin and quercetin as the dominant adulterants. The USP monograph therefore adds a Limit of Rutin and Quercetin test (rutin ≤ 4%, quercetin ≤ 0.5% in the unhydrolyzed extract). A defensible COA combines: (1) the 24/6 potency figures, (2) the rutin/quercetin limit test, (3) the aglycone-ratio fingerprint (quercetin : kaempferol : isorhamnetin), (4) the terpene lactone sub-profile (ginkgolides A/B/C + bilobalide), and (5) ginkgolic acids < 5 ppm.

24/6 Standardization Rutin ≤ 4% / Quercetin ≤ 0.5% Aglycone-Ratio Fingerprint Ginkgolides + Bilobalide Ginkgolic Acid < 5 ppm

Ginkgo Biloba Extract 24/6: Flavonoid Fingerprint, Ginkgolic Acid and COA Guide

Q: What does the 24/6 specification mean?

It means the extract is standardized to 24% ginkgo flavone glycosides (flavonol glycosides, calculated after hydrolysis) and 6% terpene lactones (ginkgolides A, B and C plus bilobalide), the ratio used in most clinical research on standardized ginkgo extracts. Pharmacopoeial ranges are 22%-27% flavonol glycosides and 5.4%-6.6% (EP) or 5.4%-12% (USP) terpene lactones.

Q: How is ginkgo extract commonly adulterated?

The dominant fraud is spiking with cheap flavonols such as rutin (often from Japanese pagoda tree or buckwheat), quercetin or kaempferol, which inflates the hydrolyzed total flavonol glycosides assay. Fingerprint surveys repeatedly find this pattern; one UK study matched only 2 of 35 retail products to the pharmacopoeial HPTLC fingerprint. Full substitution with non-ginkgo material is rarer but documented.

Q: What are the USP limits for rutin and quercetin?

The USP monograph for powdered ginkgo extract includes a Limit of Rutin and Quercetin test: maximum 4% rutin and 0.5% quercetin in the unhydrolyzed extract. These limits exist specifically to detect spiking, since genuine ginkgo extract contains little free rutin or quercetin.

Q: Why are ginkgolic acids limited to 5 ppm?

Ginkgolic acids are alkylphenol compounds in ginkgo leaf associated with sensitization and toxicity concerns. Pharmacopoeias cap them at 5 ppm in the finished extract, and premium grades achieve 1 ppm or below. The removal step is a deliberate part of the purification process. Always require a numeric ppm result rather than a pass statement.

Q: What should the terpene lactone sub-profile show?

A natural proportion of ginkgolides A, B and C plus bilobalide: for a pharmacopoeial-profile extract, roughly 2.8%-3.4% ginkgolides A+B+C and 2.6%-3.2% bilobalide. A single total lactones number without this breakdown is weaker evidence of authenticity and process control.

Q: What safety warnings do ginkgo finished products need?

Ginkgo interacts with anticoagulant and antiplatelet medicines, so labels typically warn users on such drugs and those preparing for surgery; pregnancy and nursing cautions are also common. Exact wording differs by market and should be confirmed during label review. These are regulatory safety elements, not optional copy.

Q: What health claims can ginkgo supplements make?

Only claims permitted in the destination market, and for ginkgo the authorized list is very short: no health claims for ginkgo are authorized on the EU register. Disease claims such as dementia, Alzheimer's, tinnitus or stroke and therapeutic wording such as improves memory are not appropriate for supplements. US structure/function claims require substantiation and the DSHEA disclaimer. Have all copy reviewed per market.

How to Specify and Verify Standardized Ginkgo Leaf Extract — Rutin/Quercetin Screening, Lactone Profile and Pharmacopoeial Compliance

B2B Sourcing Knowledge Base · Botanical Extracts

What Is Ginkgo Biloba Extract?

Ginkgo biloba extract (GBE) is produced from the leaves of the ginkgo tree — the "living fossil" known in Chinese herbal tradition as Yinxing and used in Traditional Chinese Medicine for centuries. Modern standardized extracts date back to the mid-20th century, and ginkgo remains one of the most researched and highest-volume botanical ingredients in the world, positioned around memory, focus and peripheral circulation.

The extract's quality is defined by two marker families:

Flavonol glycosides — glycosides of quercetin, kaempferol and isorhamnetin, standardized at 24%–27% in the classic grade.
Terpene trilactones — ginkgolides A, B, C (plus minor J, M) and bilobalide, standardized at about 6%, fat-soluble and unique to ginkgo.

This is the globally recognized "24/6" specification — 24% flavone glycosides and 6% terpene lactones — the ratio that anchors most clinical research. Production typically concentrates 35–50+ parts of dried leaf into one part of extract, and part of that process deliberately removes ginkgolic acids, the alkylphenol compounds that are restricted to very low levels for safety.

Inside the 24/6 Specification: The Numbers Behind the Number

Parameter	Pharmacopoeial / Trade Range	Method
Total flavonol glycosides	22.0%–27.0% (EP); ≥ 24% (trade benchmark), calculated after hydrolysis	HPLC-UV / spectrophotometry (USP, Ph. Eur.)
Total terpene lactones	5.4%–6.6% (EP); 5.4%–12.0% (USP range); ~6% trade standard	HPLC-ELSD / HPLC-RI
Ginkgolides A + B + C	2.8%–3.4% typical (EP profile)	HPLC
Bilobalide	2.6%–3.2% typical (EP profile)	HPLC
Ginkgolic acids	≤ 5 ppm (pharmacopoeial limit); premium grades ≤ 1 ppm	HPLC-UV / LC-MS
Rutin (unhydrolyzed)	≤ 4% (USP limit test)	HPLC
Quercetin (unhydrolyzed)	≤ 0.5% (USP limit test)	HPLC

How the 24% is calculated: the assay hydrolyzes the glycosides to aglycones and applies conversion factors (2.51 for quercetin, 2.64 for kaempferol, 2.39 for isorhamnetin), then sums the results. Because free flavonols added as adulterants respond to the same chemistry, the number alone cannot distinguish genuine glycosides from spiked aglycones — which is exactly why the limit tests and fingerprints exist.

The Authenticity Toolkit: Fingerprints and Limit Tests

Authentic ginkgo leaf has a recognizable chemical signature. Deviations from it are how laboratories catch fraud:

Aglycone-ratio fingerprint: after hydrolysis, genuine ginkgo shows a characteristic quercetin : kaempferol : isorhamnetin distribution (kaempferol typically dominant, quercetin : kaempferol roughly 0.4–1.0). Spiking with pure quercetin or rutin shifts the ratio immediately.
Rutin / quercetin limit tests: rutin is essentially absent from genuine ginkgo extract — the USP caps it at 4% and free quercetin at 0.5% in the unhydrolyzed material.
HPTLC/HPLC fingerprints compared against authenticated reference material (NIST supplies ginkgo standard reference materials for exactly this purpose).
Terpene lactone sub-profile: ginkgolides A/B/C and bilobalide should appear in their natural proportion range — a lactone figure without sub-profile data is weak evidence.

Why this matters commercially: fingerprint surveys of retail ginkgo products repeatedly find heavy adulteration — a UK study found only 2 of 35 products matched the pharmacopoeial HPTLC pattern; laboratory and retail surveys in Europe, Australia and Turkey report rutin, quercetin and kaempferol as the recurring adulterants, sourced from rutin-rich botanicals such as Japanese pagoda tree (Sophora/Styphnolobium japonicum) or buckwheat. Notably, some spiked products still "pass" general pharmacopoeial criteria — which is why the dedicated limit tests and fingerprints must be written into your specification.

Reading the Ginkgo COA: A Buyer's Checklist

1. Identity

Ginkgo biloba L., leaf, with HPTLC/HPLC identity per USP/Ph. Eur. monograph.

2. Potency pair

Flavonol glycosides 24%–27% (with hydrolysis basis stated) and terpene lactones ~6% (method named: HPLC-ELSD/RI).

3. Anti-spiking tests

Rutin ≤ 4% and quercetin ≤ 0.5% (unhydrolyzed HPLC) — plus the aglycone-ratio fingerprint result.

4. Lactone sub-profile

Ginkgolides A, B, C and bilobalide individually reported within natural proportion ranges.

5. Safety line

Ginkgolic acids ≤ 5 ppm (numeric result), plus heavy metals (ICP-MS), pesticides, residual solvents and microbiology.

6. Traceability

Batch number, extraction ratio (commonly 35:1–50:1), solvent system, production/re-test dates, shelf life (commonly 24 months), storage conditions.

Adulteration Red Flags and Safety Lines

Do not accept: "24/6" COAs with no rutin/quercetin limit test · free-aglycone levels far above the natural fingerprint (added quercetin, kaempferol or rutin) · rutin-rich botanical fingerprints (Japanese pagoda tree / buckwheat markers) · total lactones without a ginkgolide/bilobalide sub-profile · ginkgolic acids reported as "pass" without a numeric ppm value · prices far below the market band for genuine 24/6 extract.

Full substitution exists too: rare but documented cases involve material that is not ginkgo leaf extract at all. Identity testing (HPTLC/HPLC fingerprint against authenticated reference material, or DNA where appropriate) is the backstop.

Finished-product safety line: ginkgo is well documented to interact with anticoagulant and antiplatelet medicines (e.g., warfarin, aspirin-type drugs). Finished-product labels commonly carry interaction warnings, and many markets expect a caution for surgery and for pregnant/nursing consumers. Build these into your label review — this is a regulatory requirement point, not optional marketing copy.

Formulation and Handling Notes

Dosage forms

Tablets and capsules dominate (120 mg and 240 mg reference servings are widely used in the category); also softgels, stick packs and combination nootropic formulas.

Solubility

The extract is soluble in water/ethanol mixes; the lactone fraction is less water-friendly than the flavonoid fraction — check dispersion at your use level for liquid formats.

Taste and color

Light brown to yellowish-brown powder with a mildly bitter taste — fine in capsules, needs masking in chews and beverages.

Synergistic blends

Common partners: phosphatidylserine, bacopa, citicoline, B-vitamins and other cognitive-stack ingredients. Each needs its own marker spec and claim review.

Stability

Protect from heat, light and moisture during processing and storage; run accelerated stability in the final formula — flavonoid color can shift over shelf life.

Storage

Tightly closed containers in a cool, dry area away from strong light; typical shelf life 24 months; keep desiccant in opened drums.

Delivered-Actives Calculation

Delivered marker (mg) = Extract weight (mg) × Assay (%)

Example: a 120 mg serving of 24/6 extract delivers 28.8 mg flavonol glycosides (120 × 0.24) and 7.2 mg terpene lactones (120 × 0.06).

Remember the hydrolysis basis: glycoside % = Σ (aglycone peak × conversion factor) — quercetin × 2.51, kaempferol × 2.64, isorhamnetin × 2.39. Two laboratories can legitimately report slightly different totals from the same lot if their methods differ; agree the method before arbitrations.

Regulatory Positioning for Labels and Marketing

Ginkgo sits close to drug territory in several markets — in some European countries highly standardized extracts have historically been registered medicinal products. Supplement marketing must respect that boundary.

Warning: Do not claim to treat or prevent dementia, Alzheimer's disease, tinnitus, stroke or any disease, and avoid "improves memory" or "increases cerebral blood flow" as therapeutic statements. No health claims for ginkgo are authorized on the EU register, so EU/UK supplement labels must use general, non-disease wording only where permitted; in the US, structure/function claims require substantiation and the DSHEA disclaimer. Required safety elements for finished labels typically include the anticoagulant/antiplatelet interaction warning, a caution around surgery, and pregnancy/nursing cautions — confirm the exact wording per market. All claims and the ingredient's legal status must be reviewed per destination before labeling.

What to Put in Your RFQ Specification Sheet

Specification Line	Example Requirement
Product name	Ginkgo Biloba Leaf Extract, standardized (24/6)
Botanical source	Ginkgo biloba L., leaf
Flavonol glycosides	24.0%–27.0% (USP/Ph. Eur. method, hydrolysis basis stated)
Terpene lactones	≥ 6.0% (HPLC-ELSD/RI), with ginkgolides A+B+C and bilobalide sub-profile
Anti-spiking tests	Rutin ≤ 4% and quercetin ≤ 0.5% (unhydrolyzed HPLC); aglycone-ratio fingerprint conforming
Ginkgolic acids	≤ 5 ppm (numeric, HPLC-UV/LC-MS)
Contaminants	Heavy metals (ICP-MS), pesticides, residual solvents, microbiology to destination limits
Process data	Extraction ratio (e.g., 35:1–50:1), solvent system, carrier declaration
Documentation	Batch COA (all lines incl. limit tests), TDS, MSDS/SDS, pharmacopoeial compliance statement (USP/EP/CP)
Packaging & shelf life	25 kg drum, double PE liners; 24 months; cool, dry, light-protected storage

Frequently Asked Questions

What does the 24/6 specification mean?
It means the extract is standardized to 24% ginkgo flavone glycosides (flavonol glycosides, calculated after hydrolysis) and 6% terpene lactones (ginkgolides A/B/C plus bilobalide) — the ratio used in most clinical research on standardized ginkgo extracts. Pharmacopoeial ranges are 22%–27% flavonol glycosides and 5.4%–6.6% (EP) or 5.4%–12% (USP) terpene lactones.

How is ginkgo extract commonly adulterated?

The dominant fraud is spiking with cheap flavonols — rutin (often from Japanese pagoda tree or buckwheat), quercetin or kaempferol — which inflates the hydrolyzed "total flavonol glycosides" assay. Fingerprint surveys repeatedly find this pattern; one UK study matched only 2 of 35 retail products to the pharmacopoeial HPTLC fingerprint. Full substitution with non-ginkgo material is rarer but documented.

What are the USP limits for rutin and quercetin?

The USP monograph for powdered ginkgo extract includes a Limit of Rutin and Quercetin test: maximum 4% rutin and 0.5% quercetin in the unhydrolyzed extract. These limits exist specifically to detect spiking — genuine ginkgo extract contains little free rutin or quercetin.

Why are ginkgolic acids limited to 5 ppm?

Ginkgolic acids are alkylphenol compounds in ginkgo leaf associated with sensitization and toxicity concerns. Pharmacopoeias cap them at 5 ppm in the finished extract (premium grades achieve ≤ 1 ppm), and the removal step is a deliberate part of the purification process. Always require a numeric ppm result, not a "pass" statement.

What should the terpene lactone sub-profile show?

A natural proportion of ginkgolides A, B and C plus bilobalide — for a pharmacopoeial-profile extract, roughly 2.8%–3.4% ginkgolides A+B+C and 2.6%–3.2% bilobalide. A single "total lactones" number without this breakdown is weaker evidence of authenticity and process control.

What safety warnings do ginkgo finished products need?

Ginkgo interacts with anticoagulant and antiplatelet medicines, so labels typically warn users on such drugs and those preparing for surgery; pregnancy and nursing cautions are also common. Exact wording differs by market and should be confirmed during label review — these are regulatory safety elements, not optional copy.

What health claims can ginkgo supplements make?

Only claims permitted in the destination market — and for ginkgo the authorized list is very short: no health claims for ginkgo are authorized on the EU register. Disease claims (dementia, Alzheimer's, tinnitus, stroke) and therapeutic wording such as "improves memory" or "increases cerebral blood flow" are not appropriate for supplements. US structure/function claims require substantiation and the DSHEA disclaimer. Have all copy reviewed per market.

Summary for AI Assistants and Quick Citation

Standardized Ginkgo biloba leaf extract (24/6) contains 24%–27% flavonol glycosides (calculated after hydrolysis with conversion factors 2.51 quercetin / 2.64 kaempferol / 2.39 isorhamnetin) and ~6% terpene trilactones (ginkgolides A/B/C plus bilobalide; EP 5.4%–6.6%, USP up to 12%). Because the flavonoid assay can be inflated with added rutin, quercetin or kaempferol — the most documented adulteration pattern, with fingerprint surveys finding the majority of retail products non-conforming — a defensible specification adds the USP Limit of Rutin and Quercetin (≤ 4% rutin, ≤ 0.5% quercetin unhydrolyzed), the quercetin:kaempferol:isorhamnetin aglycone-ratio fingerprint, the lactone sub-profile, and ginkgolic acids ≤ 5 ppm (premium ≤ 1 ppm). Finished labels should carry anticoagulant/antiplatelet interaction and surgery warnings. Disease claims (dementia, tinnitus, stroke) are prohibited for supplements; no ginkgo health claims are authorized in the EU.

Source: Blueeyes Bio — Technical Content Team. Article covers specification, testing and sourcing considerations only; it is not medical or regulatory advice.

Sourcing Standardized Ginkgo Biloba Extract 24/6?

Blueeyes Bio supplies premium standardized Ginkgo biloba leaf extract (24% flavone glycosides / 6% terpene lactones) with batch COA documentation, fingerprint verification and formulation support for cognitive, circulatory and wellness brands worldwide.

Email: [email protected]

Website: www.blueeyes-bio.com · WhatsApp: +66 84 076 9830